Founder and Executive Chairman of the Board to Advance Quantum-Si’s Protein Sequencing Technology and Commercialization Strategy
Quantum-Si Incorporated a life sciences company commercializing single molecule protein sequencing, announced the appointment of Dr. Jonathan Rothberg, Founder and Executive Chairman of Quantum Si’s Board of Directors, as Interim CEO. Dr. Rothberg succeeds John Stark, effective February 8, 2022, while the Company’s Board of Directors commences a search process to identify a long-term CEO.
“Quantum-Si’s first-of-its-kind next generation protein sequencing has the potential to impact immunology, diagnostics and drug development in the same way that next generation DNA sequencing impacted oncology and precision medicine”
“Quantum-Si’s first-of-its-kind next generation protein sequencing has the potential to impact immunology, diagnostics and drug development in the same way that next generation DNA sequencing impacted oncology and precision medicine,” said Dr. Jonathan Rothberg. “We remain committed to the commercial launch of our groundbreaking technology in 2022. Two years into a global pandemic, this technology is more important than ever. We need to fully understand our immune response to COVID-19 as well as other pathogens.”
Recommended AI News: Insights On Latest Utility NFT About To Hit The Metaverse – IggyBoy
Dr. Rothberg is a prolific inventor, scientist and entrepreneur who has successfully founded and launched multiple life science and medical device companies, including 454 Life Sciences, AI Therapeutics, Butterfly Network, CuraGen, Detect, Hyperfine, Ion Torrent, Liminal Sciences, Protein Evolution, RainDance Technologies, Tesseract Health and Quantum-Si. In 2006, Dr. Rothberg was awarded the National Medal of Technology and Innovation by President Barack Obama for pioneering high-speed next generation DNA sequencing and ushering in the age of precision medicine.
Quantum-Si will report fourth quarter and full year 2021 financial results and provide a business update after market close on Monday, February 28, 2022.
Dr. Jonathan Rothberg’s Interim CEO Appointment Call
Quantum-Si will host a conference call to discuss the appointment of Dr. Jonathan Rothberg as Interim CEO today, February 14, 2022, at 5:00 PM Eastern Time. Individuals interested in listening to the conference call may do so by dialing (844) 200-6205 for domestic callers or (929) 526-1599 for international callers (no Conference ID is needed). A live and archived webcast of the event will be available on the Investors section of the Quantum-Si website under Events & Presentations.
Recommended AI News: Machine Learning Innovator Wallaroo Wins Backing from Microsoft’s M12 in $25Million Series A Round
[To share your insights with us, please write to sghosh@martechseries.com]
Comments are closed.